AzTrials
AzTrials

Athletic PerformanceWeightlifterNCT07837310

Effects of Play Attention Neurofeedback on Attention and Weightlifting Performance in Adolescent Weightlifters

A study testing Play Attention Neurofeedback-Based Attention Training in people with Athletic Performance and Attention, run by Hasan Erdem Mumcu at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study looks at whether a 24-week neurofeedback training program called Play Attention can help adolescent weightlifters pay better attention and lift better. Neurofeedback is a computer-based training method that shows people real-time information about their own brain activity, so they can learn to control it. Read more about this study

Who is it for?
Ages 13 to 16 years, men onlyHealthy volunteers can take part
Conditions the study is for
Athletic Performance, Attention, Neurofeedback
What is being tested?
Play Attention Neurofeedback-Based Attention Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2025to 16 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 16 years
  • Men only
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Adolescent athletes actively engaged in competitive Olympic weightlifting training
  • Minimum of [X] years of weightlifting training experience
  • No diagnosed attention-related disorder
  • Willingness and availability to complete the 24-week neurofeedback training protocol
  • Written informed consent from participant and parent/legal guardian

Who cannot join

  • Presence of a diagnosed neurological or psychiatric condition
  • Current use of medication affecting attention or cognitive function
  • Injury preventing participation in regular weightlifting training
  • Incomplete participation in the neurofeedback training sessions or outcome assessments

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Tokat Gaziosmanpasa University Faculty of Sport Science

    Center, Eyalet/Yerleşke, 60100

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of 24-Week Play Attention Neurofeedback on Attention and Weightlifting Performance: An Extended Pilot Quasi-Experimental Study in Adolescent Weightlifters

This study looks at whether a 24-week neurofeedback training program called Play Attention can help adolescent weightlifters pay better attention and lift better. Neurofeedback is a computer-based training method that shows people real-time information about their own brain activity, so they can learn to control it. In this study, adolescent weightlifters take part in the Play Attention program over 24 weeks. Researchers measure the athletes' attention skills and weightlifting performance before and after the program to see whether the training made a difference. The goal is to find out if this kind of brain-training program could be a useful tool to help young athletes focus better and perform better in their sport.

Read the detailed description

This is an extended pilot quasi-experimental study examining the effects of a 24-week Play Attention neurofeedback training program on attention and weightlifting performance in adolescent weightlifters. Play Attention is a neurofeedback-based cognitive training system that uses real-time monitoring of attention-related physiological signals, combined with interactive software tasks, to help users develop self-regulation of attentional control.

Participants undergo the Play Attention protocol over a 24-week period, integrated alongside their regular weightlifting training. Attention-related outcomes are assessed using standardized measures administered before and after the intervention period, and weightlifting performance is evaluated using sport-specific performance metrics recorded at the same time points. As a quasi-experimental design, the study does not employ randomized group allocation; comparisons are made using pre-post measurement within the study cohort.

The rationale for the study is that attentional control is a key component of technical execution and consistency in weightlifting, and that neurofeedback training targeting attention may translate into measurable improvements in both cognitive and sport performance outcomes in adolescent athletes, a population in which this type of intervention has been understudied.

Being tested
Play Attention Neurofeedback-Based Attention Training
Keywords
Sports performance, Cognitive training, Weightlifting, Play Attention, Attention training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Play Attention Neurofeedback-Based Attention TrainingBehavioural

    A commercially available neurofeedback-based attention-training system combining software with a wearable BodyWave armband, an interface unit, and Bluetooth connectivity. Participants in the experimental group completed 40 training sessions (approximately 30-40 minutes each) over 24 weeks, in addition to their routine Olympic weightlifting training. The system provides real-time visual and auditory feedback based on attention-related signal activity during game-like cognitive exercises. It is a non-clinical, non-diagnostic system; no scalp EEG was independently recorded in this study.

Study groups in NCT07837310
Study groupRoleWhat they receive
Neurofeedback Training GroupExperimentalAdolescent weightlifters who received a 24-week Play Attention neurofeedback training program in addition to their regular weightlifting training. Attention and weightlifting performance outcomes were assessed before and after the intervention period.
Receives: Behavioral: Play Attention Neurofeedback-Based Attention Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in selective and sustained attention measured by the d2 Test of Attention

    The d2 Test of Attention (Brickenkamp) is a paper-and-pencil test of selective and sustained attention and concentration. Participants scan 14 lines of 47 characters each (658 items in total) and cross out every letter "d" marked with two dashes, within a 20-second limit per line. The score used for this outcome is Concentration Performance (CP), calculated as the total number of items processed minus the total number of errors. CP ranges from a minimum of 0 to a maximum of 658. Higher scores indicate better attention performance. The test will be administered at baseline and at the end of the 24-week intervention.

    Measured: Baseline and Week 24

Secondary outcomes (3)
  1. Change in snatch one-repetition maximum (1RM), measured in kilograms

    The snatch 1RM is the maximum weight, in kilograms, that a participant can lift successfully in a single snatch attempt. Values are recorded in kilograms, with a minimum of 0 kg and no fixed upper limit. Higher values indicate better weightlifting performance. The test will be administered at baseline and at the end of the 24-week intervention.

    Measured: Baseline and week 24

  2. Change in clean and jerk one-repetition maximum (1RM), measured in kilograms

    The clean and jerk 1RM is the maximum weight, in kilograms, that a participant can lift successfully in a single clean and jerk attempt. Values are recorded in kilograms, with a minimum of 0 kg and no fixed upper limit. Higher values indicate better weightlifting performance. The test will be administered at baseline and at the end of the 24-week intervention.

    Measured: Baseline and week 24

  3. Change in weightlifting total (sum of snatch and clean and jerk 1RM), measured in kilograms

    The weightlifting total is the sum of the best successful snatch and the best successful clean and jerk attempts, in kilograms. Values have a minimum of 0 kg and no fixed upper limit. Higher values indicate better weightlifting performance. It will be assessed at baseline and at the end of the 24-week intervention.

    Measured: Baseline and week 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2026
  2. Study start1 Aug 2025
  3. Primary completion24 Oct 2025
  4. Study completion16 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Study assigns participants to two different interventions according to a structured protocol: Experimental group: Participants received Play Attention neurofeedback-based attention training (40 sessions, approximately 30-40 minutes each, delivered over 24 weeks) in addition to their routine Olympic weightlifting training program. Control group: Participants continued their routine Olympic weightlifting training only, without any neurofeedback-based attention training component. Both groups were assessed at three time points - baseline, 12 weeks, and 24 weeks - using the same outcome measures (the d2 Attention Test and weightlifting performance indicators), allowing comparison of longitudinal change between the group receiving the added cognitive-training intervention and the group receiving standard training alone.
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07837310
Sponsor's protocol ID
GOP-PA-01-24 / August 20, 2024
Acronym
Weightlifter
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data, including d2 Attention Test outcome scores (TN, E, TN-E, CP, FR) and weightlifting performance measures (total lifted weight, body mass) at baseline, 12 weeks, and 24 weeks, will be considered for sharing. Data will be de-identified prior to sharing to protect participant privacy, given that participants were minors. No directly identifying information (names, dates of birth, or contact details) will be shared under any circumstances.

Questions about this trial

What is this clinical trial studying?

A study testing Play Attention Neurofeedback-Based Attention Training in people with Athletic Performance and Attention, run by Hasan Erdem Mumcu at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in selective and sustained attention measured by the d2 Test of Attention (time frame: Baseline and Week 24). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in